Advertisement

Featured in NEJM Journal Watch: Management of Recurrent Clostridium difficile — Physician’s First Watch

Medical News |
May 12, 2014

Featured in NEJM Journal Watch: Management of Recurrent Clostridium difficile

By the NEJM Journal Watch Editors

Fecal microbiota transplantation was the most cost-effective therapy; use of frozen stool from screened healthy donors was efficacious whether administered by nasogastric tube or colonoscopically, according to two studies in Clinical Infectious Diseases.

Reader Comments (3)

Jaromir Gumulec, MD Physician, Hematology, Faculty Hospital Ostrava, Czech Republic

Are there any experiences with this treatment in patients SMith hematologické malignances?

Nadan Rustemovic, prof Physician, Gastroenterology, Univ.hospital

need more details for the frozen supernatants

JORGE JIMENEZ MD MPH Physician, Preventive Medicine, Pontificia Universidad Catolica de Chile

This is a very interesting and unexpected way to get back to normal life and nature after the excesses of antibiotic therapies.

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement